Celularity Financial Statements From 2010 to 2025

CELU Stock  USD 2.05  0.08  3.76%   
Analyzing historical trends in various income statement and balance sheet accounts from Celularity's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Celularity's valuation are summarized below:
Gross Profit
24.6 M
Profit Margin
(1.65)
Market Capitalization
54.7 M
Enterprise Value Revenue
2.7751
Revenue
44.6 M
There are currently one hundred twenty fundamental signals for Celularity that can be evaluated and compared over time across rivals. All traders should validate Celularity's prevailing fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction.

Celularity Total Revenue

56.93 Million

Check Celularity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Celularity's main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.3 M, Interest Expense of 3.4 M or Total Revenue of 56.9 M, as well as many indicators such as Price To Sales Ratio of 0.8, Dividend Yield of 0.0 or PTB Ratio of 5.41. Celularity financial statements analysis is a perfect complement when working with Celularity Valuation or Volatility modules.
  
Build AI portfolio with Celularity Stock
Check out the analysis of Celularity Correlation against competitors.
For more information on how to buy Celularity Stock please use our How to Invest in Celularity guide.

Celularity Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets126 M132.7 M121.3 M
Slightly volatile
Short and Long Term Debt Total41.1 M79.2 M21.6 M
Slightly volatile
Total Current Liabilities37.1 M53.7 M17.2 M
Slightly volatile
Other Liabilities95.8 M100.9 M269.2 M
Slightly volatile
Property Plant And Equipment Net77.2 M72.4 M37.5 M
Slightly volatile
Accounts Payable24.5 M23.3 M8.1 M
Slightly volatile
Cash701.1 K738 K6.8 M
Slightly volatile
Non Current Assets Total106.5 M112.1 M407.9 M
Slightly volatile
Cash And Short Term Investments806.3 K848.7 K6.8 M
Slightly volatile
Net Receivables7.8 M13.6 M5.5 M
Slightly volatile
Good Will6.3 M6.6 M105.6 M
Slightly volatile
Common Stock Total Equity201.1 M313.9 M117.6 M
Slightly volatile
Common Stock Shares Outstanding13.9 M21.9 M26.4 M
Slightly volatile
Liabilities And Stockholders Equity145 M152.6 M123 M
Slightly volatile
Inventory5.8 M5.4 M4.4 M
Slightly volatile
Other Current Assets814.1 K857 K2.7 M
Pretty Stable
Total Liabilities198.2 M123.8 M120.9 M
Slightly volatile
Total Current Assets29 M20.6 M13.3 M
Slightly volatile
Intangible Assets8.8 M9.2 M263.3 M
Slightly volatile
Common Stock1.7 K1.8 K16.2 M
Very volatile
Property Plant Equipment69.1 M104.2 M39.9 M
Slightly volatile
Warrants193.9 M188.2 M248.4 M
Slightly volatile
Non Current Liabilities Total66.7 M70.2 M113.5 M
Pretty Stable
Capital Surpluse28 M55.6 M18.9 M
Slightly volatile
Non Current Liabilities Other1.6 M1.7 M32.9 M
Pretty Stable
Current Deferred Revenue2.6 M3.2 M4.2 M
Slightly volatile
Capital Lease Obligations22.8 M26.5 M29.5 M
Slightly volatile
Deferred Long Term Liabilities482542591
Slightly volatile
Property Plant And Equipment Gross115.1 M105.3 M100.6 M
Slightly volatile
Capital Stock1.9 KK3.8 K
Slightly volatile
Short Term Debt13.8 M7.3 M6.3 M
Slightly volatile
Short and Long Term DebtM6.4 M33.8 M
Slightly volatile
Long Term Debt28.7 M32.3 M35.3 M
Slightly volatile

Celularity Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization8.3 M9.1 M6.3 M
Slightly volatile
Total Revenue56.9 M54.2 M22.9 M
Slightly volatile
Other Operating Expenses79.6 M106.5 M38.8 M
Slightly volatile
Research Development16.5 M17.4 M36.5 M
Pretty Stable
Cost Of Revenue8.6 M15 M7.2 M
Slightly volatile
Total Operating Expenses82.2 M77.6 M37.9 M
Slightly volatile
Selling General Administrative50.8 M58.6 M20.8 M
Slightly volatile
Selling And Marketing Expenses19.7 K20.7 K777.4 K
Slightly volatile
Interest Income274.9 K331 K355.8 K
Slightly volatile
Reconciled Depreciation9.6 M7.9 M8.4 M
Slightly volatile

Celularity Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation14.9 M11.6 M9.1 M
Slightly volatile
Begin Period Cash Flow9.7 M10.2 M30.9 M
Very volatile
Depreciation8.6 M7.9 M6.3 M
Slightly volatile
Capital Expenditures152.9 K161 K5.8 M
Pretty Stable
Total Cash From Financing Activities6.4 M6.7 M40.4 M
Slightly volatile
End Period Cash Flow10.4 M11 M11.4 M
Slightly volatile
Other Cashflows From Investing Activities2.5 MM1.4 M
Slightly volatile
Issuance Of Capital Stock5.7 MM80.1 M
Slightly volatile
Dividends Paid31.3 M35.2 M38.3 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.80.8398122
Slightly volatile
Days Sales Outstanding10291.2635105
Slightly volatile
Average Payables2.1 M2.4 M2.6 M
Slightly volatile
Stock Based Compensation To Revenue0.20.21340.4136
Slightly volatile
Capex To Depreciation0.01930.02030.8603
Pretty Stable
EV To Sales1.992.0957123
Slightly volatile
Inventory Turnover2.912.77111.825
Pretty Stable
Days Of Inventory On Hand125132278
Pretty Stable
Payables Turnover0.610.643421.8867
Very volatile
Sales General And Administrative To Revenue1.661.08120.8978
Slightly volatile
Research And Ddevelopement To Revenue0.30.32072.027
Very volatile
Capex To Revenue0.00280.0030.3245
Pretty Stable
Cash Per Share0.0320.03370.6313
Pretty Stable
Days Payables Outstanding394567387
Slightly volatile
Intangibles To Total Assets0.120.125111.9 K
Slightly volatile
Current Ratio0.360.3830.724
Pretty Stable
Receivables Turnover3.523.99943.7955
Slightly volatile
Capex Per Share0.0070.00740.5352
Pretty Stable
Revenue Per Share1.32.47681.0402
Slightly volatile
Interest Debt Per Share2.53.43061.5217
Slightly volatile
Debt To Assets0.490.51883.5319
Slightly volatile
Graham Number22.7220.7121.7729
Slightly volatile
Operating Cycle401223383
Slightly volatile
Days Of Payables Outstanding394567387
Slightly volatile
Long Term Debt To Capitalization0.640.720.7873
Slightly volatile
Net Income Per E B T0.780.90.9148
Pretty Stable
Cash Ratio0.01310.01370.5744
Pretty Stable
Days Of Inventory Outstanding125132278
Pretty Stable
Days Of Sales Outstanding10291.2635105
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.971.0252K
Slightly volatile
Fixed Asset Turnover0.990.74862.6457
Slightly volatile
Debt Ratio0.490.51883.5319
Slightly volatile
Price Sales Ratio0.80.8398122
Slightly volatile
Asset Turnover0.390.4086400
Slightly volatile

Celularity Fundamental Market Drivers

Cash And Short Term Investments738 K

Celularity Upcoming Events

2nd of April 2024
Upcoming Quarterly Report
View
27th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
2nd of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Celularity Financial Statements

Celularity shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Celularity investors may analyze each financial statement separately, they are all interrelated. The changes in Celularity's assets and liabilities, for example, are also reflected in the revenues and expenses on on Celularity's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue3.2 M2.6 M
Total Revenue54.2 M56.9 M
Cost Of Revenue15 M8.6 M
Stock Based Compensation To Revenue 0.21  0.20 
Sales General And Administrative To Revenue 1.08  1.66 
Research And Ddevelopement To Revenue 0.32  0.30 
Revenue Per Share 2.48  1.30 
Ebit Per Revenue(0.71)(0.74)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Celularity Stock Analysis

When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.